Eledon Pharmaceuticals ELDN
NASDAQ ELDN
$3.02 +0.09 (+3.07%)
As of: Sep 4, 2026 · 3:59 PM EDT

Eledon Pharmaceuticals (ELDN) Prepaid Assets (2013 - 2026)

Eledon Pharmaceuticals' (ELDN) quarterly Prepaid Assets came in at $2.5 million in Q1 2026, up 4418.18% YoY from $55000.0 in Q1 2025, and up 1024.43% on a QoQ basis from $221000.0 in Q4 2025.

Analysis

Eledon Pharmaceuticals (ELDN) Prepaid Assets (2013 - 2026) Analysis & Trends

Eledon Pharmaceuticals (ELDN) has 14 years of Prepaid Assets data on file, last reported at $2.5 million in Q1 2026.

  • Quarterly Prepaid Assets rose 4418.18% year-over-year to $2.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.5 million (up 4418.18% YoY) and the FY2025 annual result came in at $221000.0, down 93.78% from the prior year.
  • Prepaid Assets climbed to $2.5 million in Q1 2026, from $221000.0 in the prior quarter.
  • In the past five years, Prepaid Assets ranged from a high of $5.1 million in Q1 2024 to a low of $10000.0 in Q2 2025.
  • A 5-year average of $1.4 million and a median of $287000.0 in 2024 frame the typical range for Prepaid Assets.
  • Annual changes were most pronounced in 2024 — Prepaid Assets soared 10782.98% — and 2025, when it slumped 98.92%.
  • Tracing ELDN's Prepaid Assets over 5 years: stood at $3.1 million in 2022, then tumbled by 94.05% to $185000.0 in 2023, then soared by 1820.0% to $3.6 million in 2024, then sank by 93.78% to $221000.0 in 2025, then surged by 1024.43% to $2.5 million in 2026.
  • The last three Prepaid Assets figures came in at $2.5 million (Q1 2026), $221000.0 (Q4 2025), and $248000.0 (Q3 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Eledon Pharmaceuticals 344.87 Mn 344.87 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 4.34 Mn
Mar 31, 2026 2.49 Mn
Dec 31, 2025 2.35 Mn
Sep 30, 2025 2.90 Mn
Jun 30, 2025 3.83 Mn
Mar 31, 2025 2.84 Mn
Dec 31, 2024 3.55 Mn
Sep 30, 2024 3.32 Mn
Jun 30, 2024 3.61 Mn
Mar 31, 2024 5.12 Mn
Dec 31, 2023 5.03 Mn
Sep 30, 2023 3.38 Mn
Jun 30, 2023 2.24 Mn
Mar 31, 2023 2.42 Mn
Dec 31, 2022 3.11 Mn
Sep 30, 2022 1.68 Mn
Jun 30, 2022 2.33 Mn
Mar 31, 2022 2.65 Mn
Dec 31, 2021 3.51 Mn
Sep 30, 2021 1.52 Mn